Signaturefd LLC Has $1.09 Million Stake in CVS Health Co. (NYSE:CVS)

Signaturefd LLC reduced its position in shares of CVS Health Co. (NYSE:CVS) by 16.0% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 17,386 shares of the pharmacy operator’s stock after selling 3,305 shares during the quarter. Signaturefd LLC’s holdings in CVS Health were worth $1,093,000 at the end of the most recent quarter.

A number of other hedge funds also recently modified their holdings of the business. Sequoia Financial Advisors LLC raised its position in CVS Health by 49.2% during the third quarter. Sequoia Financial Advisors LLC now owns 47,708 shares of the pharmacy operator’s stock valued at $3,000,000 after buying an additional 15,741 shares during the period. Kempner Capital Management Inc. purchased a new position in CVS Health during the 3rd quarter valued at about $2,140,000. Livelsberger Financial Advisory acquired a new position in shares of CVS Health in the 3rd quarter valued at about $31,000. Wealth Advisory Solutions LLC acquired a new stake in shares of CVS Health during the third quarter worth approximately $266,000. Finally, Penn Davis Mcfarland Inc. purchased a new position in CVS Health during the third quarter valued at approximately $2,837,000. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have issued reports on CVS shares. Wells Fargo & Company increased their target price on shares of CVS Health from $60.00 to $61.00 and gave the stock an “equal weight” rating in a research report on Monday, August 12th. TD Cowen raised CVS Health from a “hold” rating to a “buy” rating and lifted their price objective for the company from $59.00 to $85.00 in a research report on Friday, October 4th. Evercore ISI upped their target price on CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 8th. Deutsche Bank Aktiengesellschaft reduced their price target on CVS Health from $64.00 to $63.00 and set a “hold” rating for the company in a report on Friday, August 9th. Finally, Cantor Fitzgerald restated a “neutral” rating and issued a $62.00 price objective on shares of CVS Health in a report on Tuesday, October 1st. Nine research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $74.89.

CVS Health Stock Performance

CVS opened at $56.78 on Thursday. CVS Health Co. has a 12-month low of $52.77 and a 12-month high of $83.25. The firm has a market capitalization of $71.28 billion, a P/E ratio of 9.98, a price-to-earnings-growth ratio of 0.93 and a beta of 0.54. The stock’s 50 day moving average price is $59.88 and its two-hundred day moving average price is $60.17. The company has a quick ratio of 0.66, a current ratio of 0.86 and a debt-to-equity ratio of 0.83.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.73 by $0.10. The business had revenue of $91.23 billion for the quarter, compared to analyst estimates of $91.41 billion. CVS Health had a net margin of 1.98% and a return on equity of 12.72%. CVS Health’s revenue was up 2.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $2.21 earnings per share. On average, equities analysts forecast that CVS Health Co. will post 6.51 earnings per share for the current year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, November 1st. Investors of record on Monday, October 21st will be paid a dividend of $0.665 per share. The ex-dividend date is Monday, October 21st. This represents a $2.66 annualized dividend and a yield of 4.68%. CVS Health’s dividend payout ratio is 46.75%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.